Big Buttons

• PFMs can get 2.5% credit card processing

  A new benefit for APC’s Pharmacy/Facility Members: They may be able to cut their credit card processing fees to just 2.5% – 2.8%. read more →

• Phoenix compounders, rise!

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Phoenix area December 5. read more →

• APC election results: directors and bylaws

  See the results of APC's elections, including four new directors and several changes to our bylaws. read more →

• Bring us your expertise — join an APC standing committee

  We’re seeking knowledgeable members for seven 2025 APC standing committees. Is that you? read more →

• You don’t have to miss our GLP-1 briefing

  Our briefing, “What's Up with GLP-1 Compounding (And What's Next)?” is now available on demand. read more →

• PCAC votes against four nominated bulk drug substances

  FDA’s Pharmacy Compounding Advisory Committee voted at a meeting Tuesday against adding four substances to the 503A bulks list. read more →

• Did someone mention glass houses?

  Oopsie! The FDA has cited Novo Nordisk for “quality lapses” at one of the company’s two Ozempic manufacturing plants. read more →

• GLP-1s: Keep your patients informed

  The P3 October newsletter is perfect for explaining GLP-1s to your patients. read more →

More News

APC CEO Scott Brunner was a guest on “On The Pen” — a YouTube channel dedicated to all things GLP-1. The topic: “Inside the Legal Battle for Compound Tirzepatide” where they discuss “the current and future state of the shortages for Zepbound and Mounjaro, focusing on how these shortages impact patients and the ongoing legal battles surrounding compounding pharmacies and branded medications.”